{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:19:14Z","timestamp":1792786754327,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002002","name":"Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beat NB Foundation","id":[{"id":"https:\/\/ror.org\/04v719x65","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010941","name":"University of Vermont","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008237","name":"Department of Surgery","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008237","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jim.2018.06.009","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T20:23:57Z","timestamp":1528835037000},"page":"51-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses"],"prefix":"10.1016","volume":"460","author":[{"given":"Girja S.","family":"Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie C.","family":"Pero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle S.","family":"Sholler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Krag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2018.06.009_bb0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jim.2018.06.009_bb0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13059-015-0620-6","article-title":"Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy","volume":"16","author":"Angelova","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.jim.2018.06.009_bb0015","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature24462","article-title":"Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer","volume":"551","author":"Balachandran","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jim.2018.06.009_bb0020","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1128\/AEM.03357-13","article-title":"Amplification and purification of T4-like Escherichia coli phages for phage therapy: from laboratory to pilot scale","volume":"80","author":"Bourdin","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.jim.2018.06.009_bb0025","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1128\/AAC.49.7.2874-2878.2005","article-title":"Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy","volume":"49","author":"Bruttin","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jim.2018.06.009_bb0030","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1158\/0008-5472.CAN-11-3722","article-title":"Exploiting the mutanome for tumor vaccination","volume":"72","author":"Castle","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.jim.2018.06.009_bb0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jim.2018.06.009_bb0040","first-page":"714","article-title":"Advances in the T7 phage display system (review)","volume":"17","author":"Deng","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jim.2018.06.009_bb0045","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0140-6736(96)04356-5","article-title":"Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine","volume":"348","author":"Eskola","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2018.06.009_bb0050","first-page":"351","article-title":"Studies in tumor autoimmunity","volume":"20","author":"Finney","year":"1960","journal-title":"Cancer Res."},{"key":"10.1016\/j.jim.2018.06.009_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045765","article-title":"Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge","volume":"7","author":"Hashemi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2018.06.009_bb0060","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/cid\/ciu582","article-title":"Immunogenicity of intradermal trivalent influenza vaccine with topical imiquimod: a double blind randomized controlled trial","volume":"59","author":"Hung","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jim.2018.06.009_bb0065","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1074\/jbc.M110.187211","article-title":"Molecular rearrangements involved in the capsid shell maturation of bacteriophage T7","volume":"286","author":"Ionel","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2018.06.009_bb0070","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/bioinformatics\/btu586","article-title":"Translating bioinformatics in oncology: guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesis","volume":"31","author":"Itzel","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jim.2018.06.009_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2017.e00407","article-title":"Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma","volume":"3","author":"Iwagami","year":"2017","journal-title":"Heliyon"},{"key":"10.1016\/j.jim.2018.06.009_bb0080","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1158\/0008-5472.CAN-05-4441","article-title":"Selection of tumor-binding ligands in cancer patients with phage display libraries","volume":"66","author":"Krag","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jim.2018.06.009_bb0085","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jim.2018.06.009_bb0090","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4161\/onci.19727","article-title":"Targeting the tumor mutanome for personalized vaccination therapy","volume":"1","author":"Kreiter","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jim.2018.06.009_bb0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ana.24020","article-title":"Sex-specific control of central nervous system autoimmunity by p38 mitogen-activated protein kinase signaling in myeloid cells","volume":"75","author":"Krementsov","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jim.2018.06.009_bb0100","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1016\/S0021-9258(18)68927-6","article-title":"Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage","volume":"263","author":"de la Cruz","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2018.06.009_bb0105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jim.2018.06.009_bb0110","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jim.2018.06.009_bb0115","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.micinf.2012.04.004","article-title":"TLP01, an mshA mutant of Vibrio cholerae O139 as vaccine candidate against cholera","volume":"14","author":"Ledon","year":"2012","journal-title":"Microbes Infect."},{"key":"10.1016\/j.jim.2018.06.009_bb0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nm.3773","article-title":"High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma","volume":"21","author":"Linnemann","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jim.2018.06.009_bb0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.smim.2015.11.002","article-title":"Cancer immunotherapy targeting neoantigens","volume":"28","author":"Lu","year":"2016","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jim.2018.06.009_bb0130","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.3390\/v7082845","article-title":"Oral application of T4 phage induces weak antibody production in the gut and in the blood","volume":"7","author":"Majewska","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.jim.2018.06.009_bb0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1389201013378671","article-title":"Phage displayed biomolecules as preventive and therapeutic agents","volume":"2","author":"Manoutcharian","year":"2001","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jim.2018.06.009_bb0140","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.vaccine.2003.10.047","article-title":"Genetic immunisation against hepatitis B using whole bacteriophage lambda particles","volume":"22","author":"March","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2018.06.009_bb0145","article-title":"Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph node","volume":"9","author":"McDaniel","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jim.2018.06.009_bb0150","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"Mcgranahan","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jim.2018.06.009_bb0155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1472-765X.2010.02916.x","article-title":"Bacteriophage applications: where are we now?","volume":"51","author":"Monk","year":"2010","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.jim.2018.06.009_bb0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jim.2018.06.009_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/CVI.05376-11","article-title":"Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores","volume":"19","author":"Peachman","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2018.06.009_bb0170","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.vaccine.2017.01.036","article-title":"Vaccine draining lymph nodes are a source of antigen-specific B cells","volume":"35","author":"Pero","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jim.2018.06.009_bb0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40259-018-0267-4","article-title":"Targeting neoantigens for personalised immunotherapy","volume":"32","author":"Pritchard","year":"2018","journal-title":"BioDrugs"},{"key":"10.1016\/j.jim.2018.06.009_bb0180","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1158\/1078-0432.CCR-15-0233","article-title":"Vaccination with melanoma helper peptides induces antibody responses associated with improved overall survival","volume":"21","author":"Reed","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jim.2018.06.009_bb0185","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/cr.2012.30","article-title":"RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings","volume":"22","author":"Ren","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.jim.2018.06.009_bb0190","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jim.2018.06.009_bb0195","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jim.2018.06.009_bb0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13073-015-0159-x","article-title":"Hypermutation takes the driver's seat","volume":"7","author":"Schlesner","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/j.jim.2018.06.009_bb0205","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1046\/j.1365-2222.2002.01527.x","article-title":"Phage-displayed Bet mim 1, a mimotope of the major birch pollen allergen Bet v 1, induces B cell responses to the natural antigen using bystander T cell help","volume":"32","author":"Scholl","year":"2002","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jim.2018.06.009_bb0210","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00262-013-1443-5","article-title":"Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies","volume":"62","author":"Shukla","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jim.2018.06.009_bb0215","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12967-017-1283-8","article-title":"Vaccine-draining lymph nodes of cancer patients for generating anti-cancer antibodies","volume":"15","author":"Shukla","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jim.2018.06.009_bb0220","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1245\/s10434-008-0046-4","article-title":"Evaluation of the sentinel immunized node for immune monitoring of cancer vaccines","volume":"15","author":"Slingluff","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jim.2018.06.009_bb0225","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2018.06.009_bb0230","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jmv.20479","article-title":"Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7","volume":"77","author":"Tan","year":"2005","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jim.2018.06.009_bb0235","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2015.12.001","article-title":"Mutanome directed cancer immunotherapy","volume":"39","author":"Vormehr","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jim.2018.06.009_bb0240","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.vetmic.2017.04.023","article-title":"Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV)","volume":"205","author":"Xu","year":"2017","journal-title":"Vet. Microbiol."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175918301637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175918301637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T11:56:29Z","timestamp":1661428589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175918301637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":48,"alternative-id":["S0022175918301637"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2018.06.009","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2018.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}